Niemann-Pick type C (NPC) disease is an autosomal recessive storage disorder, character-ized by abnormal sequestration of unesterified cholesterol in the late endo-lysosomal system of cells. Progressive neurological deterioration and the onset of symptoms, such as ataxia, seizures, cognitive decline, and severe dementia, are pathognomonic features of the disease. In addition, different pathological similarities, including degeneration of hippocampal and cortical neurons, hyperphos-phorylated tau, and neurofibrillary tangle formation, have been identified between NPC disease and other neurodegenerative pathologies. However, the underlying pathophysiological mechanisms are not yet well understood, and even a real cure to counteract neurodegeneration has not been identified. Therefore, the combination of current pharmacological therapies, represented by miglustat and cyclodextrin, and non-pharmacological approaches, such as physical exercise and appropriate diet, could represent a strategy to improve the quality of life of NPC patients. Based on this evidence, in our review we focused on the neurodegenerative aspects of NPC disease, summarizing the current knowledge on the molecular and biochemical mechanisms responsible for cognitive impairment, and suggesting physical exercise and nutritional treatments as additional non-pharmacologic approaches to reduce the progression and neurodegenerative course of NPC disease.

Neurodegeneration in Niemann-pick type c disease: an updated review on pharmacological and non-pharmacological approaches to counteract brain and cognitive impairment / Cariati, I.; Masuelli, L.; Bei, R.; Tancredi, V.; Frank, C.; D'arcangelo, G.. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - 22:12(2021). [10.3390/ijms22126600]

Neurodegeneration in Niemann-pick type c disease: an updated review on pharmacological and non-pharmacological approaches to counteract brain and cognitive impairment

Masuelli L.;
2021

Abstract

Niemann-Pick type C (NPC) disease is an autosomal recessive storage disorder, character-ized by abnormal sequestration of unesterified cholesterol in the late endo-lysosomal system of cells. Progressive neurological deterioration and the onset of symptoms, such as ataxia, seizures, cognitive decline, and severe dementia, are pathognomonic features of the disease. In addition, different pathological similarities, including degeneration of hippocampal and cortical neurons, hyperphos-phorylated tau, and neurofibrillary tangle formation, have been identified between NPC disease and other neurodegenerative pathologies. However, the underlying pathophysiological mechanisms are not yet well understood, and even a real cure to counteract neurodegeneration has not been identified. Therefore, the combination of current pharmacological therapies, represented by miglustat and cyclodextrin, and non-pharmacological approaches, such as physical exercise and appropriate diet, could represent a strategy to improve the quality of life of NPC patients. Based on this evidence, in our review we focused on the neurodegenerative aspects of NPC disease, summarizing the current knowledge on the molecular and biochemical mechanisms responsible for cognitive impairment, and suggesting physical exercise and nutritional treatments as additional non-pharmacologic approaches to reduce the progression and neurodegenerative course of NPC disease.
2021
cognitive decline; lipid trafficking; neurodegeneration; Niemann-pick type C; nutritional approach; pharmacological treatment; physical exercise
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Neurodegeneration in Niemann-pick type c disease: an updated review on pharmacological and non-pharmacological approaches to counteract brain and cognitive impairment / Cariati, I.; Masuelli, L.; Bei, R.; Tancredi, V.; Frank, C.; D'arcangelo, G.. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - 22:12(2021). [10.3390/ijms22126600]
File allegati a questo prodotto
File Dimensione Formato  
Cariati_Neurodegeneration_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.53 MB
Formato Adobe PDF
2.53 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1561899
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 17
social impact